Tenax Therapeutics
TENX
22 hedge funds and large institutions have $40.1M invested in Tenax Therapeutics in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 0 closing their positions.
12% more capital invested
Capital invested by funds: $35.8M → $40.1M (+$4.22M)
5% more funds holding
Funds holding: 21 → 22 (+1)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$2.9M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$311K |
| 3 |
B
Bailard
Foster City,
California
|
+$207K |
| 4 |
BCM
Bourgeon Capital Management
Darien,
Connecticut
|
+$104K |
| 5 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
+$104K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
-$1.45M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$830K |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$311K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$207K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$104K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
26
BlackRock Advisors
Wilmington,
Delaware
| $6K | – | – | – |
|
27
Morgan Stanley
New York
| $6K | – | – | – |
|
|
AIG
28
American International Group
New York
| $4K | – | – | – |
|
|
BJ
29
BlackRock Japan
Tokyo,
Japan
| $4K | – | – | – |
|
|
IA
30
IFP Advisors
Tampa,
Florida
| $2K | – | – | – |
|
|
IWMPD
31
Integrated Wealth Management (Palm Desert)
Palm Desert,
California
| $2K | – | – | – |
|
32
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
|
TRCT
33
Tower Research Capital (TRC)
New York
| $1K | – | – | – |
|
|
KCM
34
Karp Capital Management
Sausalito,
California
| – | -$2K | – | – |
|
TENX Hedge Fund Activity: Q4 2015 in Review
22 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q4 2015, worth a combined $40.1M — up 12% from $35.8M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new TENX positions and 0 closed out — a net gain of 1 holder — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Armistice Capital, adding an estimated $2.9M. The largest seller was Commerzbank Aktiengesellschaft, cutting an estimated $1.45M.
- 22 institutional investors held Tenax Therapeutics (TENX) as of Q4 2015, up from 21 in Q3 2015.
- Funds reported $40.1M of Tenax Therapeutics stock for Q4 2015, up 12% quarter-over-quarter.
- 1 fund opened new Tenax Therapeutics positions in Q4 2015 and 0 closed out, a net change of +1 holder.
- The largest Tenax Therapeutics buyer in Q4 2015 was Armistice Capital, an estimated $2.9M added.
- The largest Tenax Therapeutics seller in Q4 2015 was Commerzbank Aktiengesellschaft, an estimated $1.45M sold.
Based on aggregated 13F filings for Q4 2015.